Total submissions: 15
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000080431 | SCV000112333 | benign | not specified | 2012-08-20 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000080431 | SCV000168153 | benign | not specified | 2014-04-09 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Laboratory for Molecular Medicine, |
RCV000080431 | SCV000268943 | benign | not specified | 2015-07-23 | criteria provided, single submitter | clinical testing | p.Leu3597Leu in exon 75 of DMD: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue, is not located withi n the splice consensus sequence, and has been identified in 0.7% (338/47956) of European chromosomes, including 129 hemizygotes, by the Exome Aggregation Consor tium (ExAC, http://exac.broadinstitute.org; dbSNP rs1800281). |
Invitae | RCV001083487 | SCV000288038 | benign | Duchenne muscular dystrophy | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000249277 | SCV000317891 | benign | Cardiovascular phenotype | 2015-06-11 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Illumina Laboratory Services, |
RCV000290962 | SCV000482216 | likely benign | Dilated cardiomyopathy 3B | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
ARUP Laboratories, |
RCV000755512 | SCV000603358 | benign | not provided | 2023-10-23 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000080431 | SCV001370631 | benign | not specified | 2020-05-15 | criteria provided, single submitter | clinical testing | |
Pars Genome Lab | RCV001083487 | SCV001736809 | benign | Duchenne muscular dystrophy | 2021-05-18 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000080431 | SCV002066104 | benign | not specified | 2019-08-15 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002504992 | SCV002806540 | likely benign | Becker muscular dystrophy; Duchenne muscular dystrophy; Dilated cardiomyopathy 3B | 2022-02-18 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000755512 | SCV001742692 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000755512 | SCV001927599 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000755512 | SCV001973432 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Natera, |
RCV001831826 | SCV002077587 | likely benign | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2020-01-11 | no assertion criteria provided | clinical testing |